Open Access

Welcome and Introductions, Program Overview.

Topic: Cardiovascular Risk Assessment
Sponsored by Amarin Pharma, Inc.

Congress Presentation

About the speaker

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
65 presentations
10 followers

4 more presentations in this session

Hypertriglyceridaemia as a Causal Factor and Target for Therapy.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Thumbnail

Clinical Trial Evidence of Omega-3 Fatty Acids in ASCVD.

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Practical Considerations on Using Omega-3 Fatty Acids to Prevent ASCVD.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Thumbnail

Live Q&A and Adjourn.

Speaker: Professor P. Steg (Paris, FR) Professor B. Nordestgaard (Copenhagen, DK)

Thumbnail

Access the full session

Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl

Speakers: Professor P. Steg, Professor B. Nordestgaard, Professor P. Steg, Professor B. Nordestgaard, Professor P. Steg...
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by